[HTML][HTML] Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, D Hossain, MA Haq… - BMC infectious …, 2020 - Springer
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

A Mily, P Sarker, I Taznin, D Hossain… - BMC Infectious …, 2020 - europepmc.org
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

[PDF][PDF] Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, D Hossain, MA Haq… - 2020 - academia.edu
Background: Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

[HTML][HTML] Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, D Hossain… - BMC Infectious …, 2020 - ncbi.nlm.nih.gov
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

[引用][C] Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, D Hossain… - BMC Infectious …, 2020 - jglobal.jst.go.jp
Slow radiological improvement and persistent low-grade inflammation after chemotherapy
in tuberculosis patients with type 2 diabetes | Article Information | J-GLOBAL Art J-GLOBAL …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

A Mily, P Sarker, I Taznin, D Hossain, MA Haq… - BMC Infectious …, 2020 - go.gale.com
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.

A Mily, P Sarker, I Taznin, D Hossain, MA Haq… - 2020 - cabidigitallibrary.org
Background: Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, D Hossain… - BMC infectious …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, DHA Haq… - BMC Infectious …, 2020 - search.proquest.com
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

A Mily, P Sarker, I Taznin, MD Hossain, MA Haq… - 2020 - researchsquare.com
Background: Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis
(TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate …